Document Detail

Beyond survival: the burden of disease in decision making in organ transplantation.
MedLine Citation:
PMID:  15367209     Owner:  NLM     Status:  MEDLINE    
Organ transplantation has long been perceived as a life-saving intervention. However, it is now recognized that the broader objectives include reducing the patient's burden of disease. The components of the burden of disease include (i) mortality, (ii) morbidity, (iii) disability, (iv) psychological distress and (v) resource use. These components may be correlated either positively or negatively, reflecting common disease antecedents or the trade-offs in clinical decisions. Our proposed approach to modeling includes measures of each outcome and, explicitly, their correlations. Its results are the predicted independent and joint probabilities that a patient will experience any specified range of each measure and of combinations of the measures. The methods were tested with data on mortality, morbidity and resource use from patients following kidney transplantation. The predicted probabilities of the measures are consistent with their observed values and distinguish among the prognoses of patients with distinctive risks, such as diabetics. We have shown, and we believe, that it is feasible to assess the interrelated components of the burden of disease in individual patients and hope that our approach may serve as a starting point in the development of a program for inclusion of alternative measures of outcome in decision making in organ transplantation.
Henry Krakauer; R Clifton Bailey; Monica J-Y Lin
Related Documents :
11871049 - Use of behavioral contingency contracting with heart transplant candidates.
15839369 - Development of an educational booklet for children of adult liver transplant recipients.
16402209 - Surgical correction of spinal deformities after solid organ transplantation in childhood.
20847719 - Balamuthia mandrillaris transmitted through organ transplantation --- mississippi, 2009.
15614139 - Procuring organ donors as a health investment: how much should we be willing to spend?
23159949 - Gut bacteria drive kupffer cell expansion via mamp-mediated icam-1 induction on sinusoi...
8333149 - When and why do heart transplant recipients die? a 7 year experience of 1068 cardiac tr...
16141459 - Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on ...
9398959 - Continuous haemodiafiltration during and after cardiopulmonary bypass in renal failure ...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons     Volume:  4     ISSN:  1600-6135     ISO Abbreviation:  Am. J. Transplant.     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-09-15     Completed Date:  2005-03-08     Revised Date:  2007-02-14    
Medline Journal Info:
Nlm Unique ID:  100968638     Medline TA:  Am J Transplant     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  1555-61     Citation Subset:  IM    
Division of Transplantation, SPB, HRSA, Bethesda, MD 20814, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cost of Illness*
Decision Making*
Diabetes Mellitus / economics,  mortality,  physiopathology
Kidney Transplantation / economics,  ethics
Organ Transplantation / economics,  ethics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A gene encoding, prespore-cell-inducing factor in Dictyostelium discoideum.
Next Document:  Banff 2003 meeting report: new diagnostic insights and standards.